Bill Ackman lists £3.5 billion hedge fund in London as it looks for Brexit growth
Hedge fund manager Bill Ackman has listed his Pershing Square Holdings fund in London. The company launched a share buyback of the fund on Tuesday. Pershing Square’s listing on the London Stock Exchange More...
Bill Ackman’s Pershing Square Sells $835 Million in Mondelez Shares
Bill Ackman’s said he sold nearly $835 million in shares of the snack food maker Mondelez. The announcement comes one day after Ackman’s hedge fund Pershing Square’s investment in Valeant More...
Bill Ackman Loses $321 Million in One Day After Valeant Plunges
Even for the beleaguered shareholders of Valeant Pharmaceuticals International Inc., Monday was an unusually bad day. The company’s biggest owner, investment firm Ruane Cunniff & Goldfarb, lost an estimated More...
Valeant, Ackman must face U.S. insider trading lawsuit
A U.S. judge said Valeant Pharmaceuticals International Inc (VRX.TO) (VRX.N) and activist hedge fund manager William Ackman must face a lawsuit accusing them of insider trading in Allergan Inc before More...
Goldman sold 1.3 million Valeant shares backing loan to CEO, Valeant says
Valeant Issues Statement On Sales Of Company Stock as follow: Valeant Pharmaceuticals International, Inc. stated that 1, 297, 399 shares pledged to Goldman Sachs to secure loans made to chairman and More...
Warburg Pincus Said to Opt Out of Buying Brazilian Bank’s Shares – Bloomberg
Warburg Pincus LLC, the New York-based private-equity firm, won’t buy more shares of Banco Indusval SA as the Brazilian bank sells stock to raise $20 million in capital, according to two people More...
What Plans Does Bill Ackman Have for Valeant with his $3.3 Billion Stake?
Pershing Square’s Bill Ackman didn’t manage to make Valeant into a successful hunter, so one wonders, with his $3.3 billion stake, as reported by Reuters, will he make Valeant, like he did Allergan, More...
Allergan CEO Says Fighting Off Activist Bill Ackman Was Full Time Job
One thing Allergan CEO David Pyott enjoyed doing was running his company. When activist investor Bill Ackman of Pershing Square decided to have Valeant Pharmaceuticals try to swallow up the Botox maker in a More...
Ackman supports Allergan’s $66 billion sale to Actavis
– Activist investor William “Bill” Ackman said on Tuesday he supports the $66 billion deal in which Actavis PLC will buy Allergan Inc and will withdraw his request for an Allergan special shareholder More...